Company Profile

Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing cell and gene therapies for serious diseases. Abeona’s lead clinical program is EB-101, its investigational autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa in Phase 3 development. The Company’s development portfolio also features AAV-based gene therapies for ophthalmic diseases with high unmet medical need.

Latest Presentation

Contact Information

Investor Relations

Company Contact
Abeona Therapeutics Inc.
1330 Avenue of the Americas
33rd Floor
New York, NY 10019